HHS Awards $13.7M for MDS Natural History Study Data Coordinating Center
Contract Overview
Contract Amount: $13,756,583 ($13.8M)
Contractor: THE Emmes Company, LLC
Awarding Agency: Department of Health and Human Services
Start Date: 2016-08-30
End Date: 2025-12-31
Contract Duration: 3,410 days
Daily Burn Rate: $4.0K/day
Competition Type: FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Pricing Type: COST PLUS AWARD FEE
Sector: R&D
Official Description: IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, DATA COORDINATING CENTER (DCC), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018
Place of Performance
Location: ROCKVILLE, MONTGOMERY County, MARYLAND, 20850
State: Maryland Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $13.8 million to THE EMMES COMPANY, LLC for work described as: IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, DATA COORDINATING CENTER (DCC), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018 Key points: 1. The contract supports critical research into Myelodysplastic Syndromes (MDS). 2. The Emmes Company, LLC, is the contractor for this data coordinating center. 3. This task order is part of a larger contract with a significant duration. 4. The award type is Cost Plus Award Fee, indicating performance-based incentives.
Value Assessment
Rating: good
The contract's Cost Plus Award Fee structure suggests a focus on performance and value. Benchmarking against similar research data coordinating center contracts would provide further insight into pricing efficiency.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition after exclusion of sources, indicating a competitive process. This method generally promotes price discovery and ensures fair market value.
Taxpayer Impact: Taxpayer funds are being used to advance critical medical research, potentially leading to better treatments and understanding of MDS.
Public Impact
Advancement of research into Myelodysplastic Syndromes (MDS), a group of blood cancers. Potential for improved diagnostic and treatment strategies for MDS patients. Contribution to the broader understanding of blood disorders and their progression. Support for scientific inquiry through data coordination and management.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Contract duration extends significantly beyond the initial task order period.
- The 'Cost Plus Award Fee' structure requires careful monitoring of performance metrics to ensure value.
Positive Signals
- Supports critical medical research in an important disease area.
- Awarded through full and open competition, suggesting a competitive process.
- The Emmes Company has a history of supporting NIH research.
Sector Analysis
This contract falls under Research and Development in the Life Sciences. Spending in this sector is crucial for medical advancements and public health initiatives. Benchmarks for similar data coordinating centers would be valuable.
Small Business Impact
The provided data does not indicate whether small businesses were involved in this specific award or subcontracting opportunities.
Oversight & Accountability
Oversight is likely managed by the National Institutes of Health (NIH) through contract performance reviews and milestone tracking. The 'Award Fee' component suggests performance-based oversight.
Related Government Programs
- Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Extended contract duration beyond initial task order.
- Potential for cost overruns with Cost Plus Award Fee structure if not managed tightly.
- Dependence on a single contractor for critical data coordination.
- Lack of specific performance metrics in the provided data.
Tags
research-and-development-in-the-physical, department-of-health-and-human-services, md, delivery-order, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $13.8 million to THE EMMES COMPANY, LLC. IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, DATA COORDINATING CENTER (DCC), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018
Who is the contractor on this award?
The obligated recipient is THE EMMES COMPANY, LLC.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $13.8 million.
What is the period of performance?
Start: 2016-08-30. End: 2025-12-31.
What is the total value of the base contract and all subsequent task orders, beyond this specific award?
The provided data only details Task Order 03. To assess the full scope and value, information on the base contract and any other awarded task orders would be necessary. This would allow for a comprehensive understanding of the total investment in the MDS Natural History Study Data Coordinating Center.
How does the Cost Plus Award Fee structure compare to fixed-price or other contract types for similar research data coordination services?
Cost Plus Award Fee contracts allow for reimbursement of costs plus an award fee based on performance. This can incentivize high performance but may lead to higher overall costs compared to fixed-price contracts. Benchmarking against similar contracts is essential to determine if this structure yielded optimal value for the government.
What are the key performance indicators (KPIs) used to determine the award fee for this contract?
The specific KPIs for the award fee are not detailed in the provided data. Typically, for a data coordinating center, KPIs would include data accuracy, timeliness of data submission, system uptime, adherence to protocols, and successful management of research participants' data. These would be defined in the contract's Statement of Work.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Pricing Type: COST PLUS AWARD FEE (R)
Evaluated Preference: NONE
Contractor Details
Address: 401 N WASHINGTON ST STE 700, ROCKVILLE, MD, 20850
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $13,756,583
Exercised Options: $13,756,583
Current Obligation: $13,756,583
Actual Outlays: $8,028,734
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: HHSN268201400002I
IDV Type: IDC
Timeline
Start Date: 2016-08-30
Current End Date: 2025-12-31
Potential End Date: 2025-12-31 00:00:00
Last Modified: 2025-09-02
More Contracts from THE Emmes Company, LLC
- Statistical and Data Coordinating Center for Clinical Research in Infectious Diseases (sdcc) — $169.2M (Department of Health and Human Services)
- - Statistical and Data Coordinating Center for Clinical Research in Infectious Diseases(sdcc) — $100.2M (Department of Health and Human Services)
- Data Coordinating Center for the Best Pharmaceuticals for Children ACT — $61.3M (Department of Health and Human Services)
- Statistical and Data Coordinating Center (sdcc) for Support of Clinical Research in Infectious Diseases — $50.3M (Department of Health and Human Services)
- Clinical Trials and Information Management Support — $42.7M (Department of Health and Human Services)
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →